Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort: does the ADDITION validation add up?

Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort: does the ADDITION validation add up?

Bibliografiske detaljer
Main Authors:	Gray, A, Holman, R, Clarke, P, Leal, J
Format:	Journal article
Sprog:	English
Udgivet:	2014

Lignende værker

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.
af: Leal, J, et al.
Udgivet: (2013)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
af: Stevens, R, et al.
Udgivet: (2004)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
af: Leal, J, et al.
Udgivet: (2021)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
af: Alva, M, et al.
Udgivet: (2014)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
af: Hayes, A, et al.
Udgivet: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
af: Hayes, A, et al.
Udgivet: (2013)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
af: Wright, A, et al.
Udgivet: (1998)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
af: Davis, T, et al.
Udgivet: (2013)

Risk factors for neuropathy in UKPDS
af: Stratton, I, et al.
Udgivet: (2004)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
af: Keavney, B, et al.
Udgivet: (1995)

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).
af: Clarke, P, et al.
Udgivet: (2002)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
af: Clarke, P, et al.
Udgivet: (2004)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
af: Stevens, R, et al.
Udgivet: (2000)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
af: Kohner, E, et al.
Udgivet: (2001)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
af: Stratton, I, et al.
Udgivet: (2006)

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).
af: Gray, A, et al.
Udgivet: (2002)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
af: Holman, R, et al.
Udgivet: (2001)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
af: Holman, R
Udgivet: (2007)

Ethnic differences in diabetic nephropathy - The UKPDS
af: Stevens, R, et al.
Udgivet: (1999)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
af: Wright, A, et al.
Udgivet: (2002)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
af: Cull, C, et al.
Udgivet: (2001)

UKPDS: what was the question? UK Prospective Diabetes Study.
af: Turner, R, et al.
Udgivet: (1999)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
af: Gray, A, et al.
Udgivet: (2001)

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
af: Clarke, P, et al.
Udgivet: (2003)

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
af: Clarke, P, et al.
Udgivet: (2005)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
af: Adler, A, et al.
Udgivet: (2000)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
af: Cull, C, et al.
Udgivet: (2004)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
af: Davis, T, et al.
Udgivet: (1999)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
af: Matthews, DR, et al.
Udgivet: (1998)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
af: Rury Holman
Udgivet: (2022-09-01)

Men and women in marriage: does it add up?
af: Biggar, N
Udgivet: (2014)

Why the subtraction argument does not add up
af: Paseau, A
Udgivet: (2002)

Does the negative binomial distribution add up?
af: Grafen, A, et al.
Udgivet: (1993)

Mathematics And Medicine: Does It All Add Up?
af: Neil S Cherniack
Udgivet: (2009-05-01)

Obesity, ageing and outcomes following myocardial infarction: Additional insights
af: Jes Jose, et al.
Udgivet: (2022-09-01)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
af: Coleman, R, et al.
Udgivet: (2005)

Ukpds risk engine
af: Daniel Pinto
Udgivet: (2011-01-01)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
af: Clarke, P, et al.
Udgivet: (2001)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
af: Kothari, V, et al.
Udgivet: (2002)

Estimating the quality of life impact of diabetes related complications: new results from the UKPDS
af: Alva, M, et al.
Udgivet: (2010)